Home / Telehealth Consulting
Build a Regenerative Health Business
Without the Brick-and-Mortar.
Lower overhead. Geographic flexibility. The same ACG system that has launched 350+ clinics — applied to a virtual delivery model. Same expertise. Different infrastructure.
Book Your Strategy CallFree 30-minute call · No obligation
What the Telehealth Model Changes —
and What Stays Exactly the Same
The telehealth model is not a lesser version and not a workaround. It is the same ACG system applied to a different delivery infrastructure. Here is what that means specifically.
- No commercial lease required
- No buildout costs
- No equipment purchases for most modalities
- Lower startup capital requirement
- Serve patients across multiple states with proper licensing
- Geographic flexibility — operate from anywhere
- Medical Director relationship required
- State licensing required for each target state
- DEA considerations for certain compounds unchanged
- Protocol compliance and informed consent requirements
- HIPAA compliance non-negotiable
- Patient acquisition still requires a real strategy
The complexity doesn't disappear with telehealth. It shifts. ACG navigates both versions.
The Market Opportunity Is Real.
The Timing Is Right.
Telehealth usage is 38x higher than pre-2020 levels (McKinsey). The infrastructure patients needed to trust a virtual clinical relationship has normalized. What hasn't been built yet is the premium, relationship-based telehealth practice that patients choose because of the quality of the clinical partnership.
Hormone therapy, GLP-1, and peptide therapy are the three highest-demand telehealth categories in cash-pay health. TRT telehealth consulting, peptide therapy telehealth, and GLP-1 telehealth clinic setup are exactly the categories ACG has structured virtually — across multiple states and multiple delivery models.
The commodity telehealth operators own price-conscious patients. The premium, relationship-based telehealth clinic owns the patient who wants real clinical partnership. That is the business ACG builds — regardless of whether it has walls.
"Telehealth regulation is complex and it changes. We track it. Our clients don't have to." — ACG
Relative demand index — directional indicator only. Not exact search volume. ACG brand colors.
Source: McKinsey & Company, 2023. Demand categories reflect ACG internal engagement data and publicly available search trend data.
Telehealth Regulation Is Complex.
ACG Knows It Cold.
Telehealth regulation is the #1 concern for every serious buyer in this category. ACG names it specifically and demonstrates expertise — because the variation is exactly why working without guidance is expensive.
What is permissible in one state requires different structuring in another. Prescribing authority, scope-of-practice rules, and licensing requirements are mapped specifically for each target state as part of ACG's telehealth setup.
The Ryan Haight Act governs controlled substance prescribing via telehealth — including testosterone and certain compounds. ACG frames the current regulatory status accurately and structures each engagement accordingly. This affects some compounds, not all telehealth services.
Prescribing flexibilities introduced during the COVID-19 public health emergency have continued to evolve. Their current status affects specific controlled substance prescribing via telehealth and is tracked and navigated by ACG.
Nurse Practitioner prescribing authority in telehealth varies significantly by state — full practice, reduced practice, or restricted practice. ACG's MD network spans 46 states and is applied to virtual delivery with state-specific agreements.
"The variation is exactly why working without guidance is expensive. ACG has navigated this across multiple states. Our clients don't track regulation — we do."
What ACG Delivers
on Every Telehealth Engagement
Transparent about what is always included. Honest about what is scoped on the call. The honesty about variable scope is positioned as a feature — ACG doesn't use a generic playbook for every telehealth engagement because the state-by-state and service-specific variation makes that impossible to do correctly.
- Medical Director introduction and oversight agreements
- State licensing navigation for target markets
- Protocol development with MD sign-off
- HIPAA-compliant intake and EMR setup
- Organic-first marketing infrastructure
- Supplier connections for compounded and clinical products
- 60-day target launch — market and regulatory conditions permitting
- Specific states to serve and licensing sequence
- Service menu — hormone, peptide, weight loss, or combination
- Prescribing structure for specific compound categories
- Paid advertising feasibility by category and platform
- Multi-state expansion roadmap
"Because telehealth engagements vary by state and service focus, we scope the specific deliverable set during the strategy call. This is honesty — not vagueness. It's what we do instead of forcing every client into a generic template."
Specific, Selective, Honest
The telehealth model is the right fit for some operators and not others. ACG is direct about both.
- You value location flexibility and want to operate without a physical office
- You're in a high-cost metro where physical overhead is prohibitive at launch
- You want to test patient demand in a market before committing to a lease
- Your service focus is hormone therapy, peptide programs, or metabolic weight loss — the three highest-volume telehealth categories
- You're tech-comfortable and can manage a virtual patient relationship
- You're thinking about building telehealth first, then adding a physical location as volume grows
- If your primary services require in-person administration — IV therapy, injectables, procedures, shockwave — a physical location is required
- ACG sets those up too. The physical clinic launch engagement has its own path
- Not sure which model fits your situation? That is what the 30-minute strategy call is for
Not sure which model fits your situation? That's what the 30-minute strategy call is for.
The Premium Telehealth Health Market Is Three Years Old. The Operators Moving Now Are Establishing the Brands
That Will Define It.
The commodity players already moved. What isn't built yet is the premium, relationship-based telehealth practice patients choose because of the quality of the clinical partnership. That is the ACG model — applied to virtual delivery.
Book the Strategy CallQuestions About the
Telehealth Model
Lower Overhead. Same Opportunity.
The ACG System.
We look at your target service area, service focus, and whether the telehealth model is the right fit.
If the physical clinic is the better path — we tell you that too. Clarity first.
Book Your 30-Minute Strategy CallACG is a consulting and advisory firm. Telehealth prescribing varies by state — ACG navigates this with you. No medical efficacy claims are made for any telehealth-delivered protocol. Timeline: targeting 60-day launch window, market and regulatory conditions permitting.